MarketInOut Stock Screener Log In | Sign Up
 

Brainsway Ltd ADR

NASDAQ • Healthcare • Medical Devices • Quote as of 10/23/2026
Brainsway Ltd ADR stock price and volume chart

Company Profile

IndustryMedical Devices
SectorHealthcare
ExchangeNASDAQ
Market Capitalization449.22 mln
Float29.59 mln
Earnings Date11/18/2026

EPS

0.23
Overpriced

P / E

48.91
High premium

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-1.1
Manipulation likely

Relative Strength

38 / 100
Underperforming

Debt / Equity

0.09
Debt-free

Business Description

Founded in Jerusalem in 2003, BrainsWay designs and markets a brain stimulation technology that treats a wide range of mental health and neurological conditions without surgery or medication. Its core device uses deep magnetic fields to target specific areas of the brain, helping patients with conditions such as depression, OCD, addiction, PTSD, and Parkinson's disease, among others. The company works with psychiatrists, hospitals, and medical centers across the United States, East Asia, and other markets worldwide.

Key Fundamentals

EPS0.23
P/E48.91
ROE12.73
RPS1.56
ROIC13.68
ROA8.08
Interest Cover3.44
EBITDA, mln13.64
EV / EBITDA33.93
EV / EBIT38.67
Revenue, mln61.10
EV / Revenue7.57

Quote Details

Last 11.25
Change -0.19 (-1.66%)
Open 11.40
Volume 51,434
Turnover 578,632
Average Volume 108,691

Financial Ratios

Pre-Tax Profit Margin16
Leverage Ratio1.54
Current Ratio3.59
Price / Book6.70
Price / Tangible Book6.70
Price / Cash Flow62.81
Price / Free Cash Flow104
Debt / Equity0.09
Price / Sales8.05

Financial Strength

Altman Z-Score8.07
Piotroski F-Score 6 / 9
Beneish M-Score-1.1
Price to Intrinsic Value5.45
Price to Graham Number3.94
Short Ratio2.78
Short % of Float0.82

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -1.66% 29 / 100   
1 Month -14.84% 23 / 100   
2 Months -31.82% 15 / 100   
6 Months -31.28% 20 / 100   
1 Year 39.23% 89 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog